BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

962 related articles for article (PubMed ID: 15788499)

  • 21. [Polycystic ovary syndrome and hair unit function disturbances in dermatological practice].
    Szpringer EA; Lutnicki KR; Zych IS
    Wiad Lek; 2006; 59(11-12):848-54. PubMed ID: 17427503
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Drug treatments for polycystic ovary syndrome.
    Radosh L
    Am Fam Physician; 2009 Apr; 79(8):671-6. PubMed ID: 19405411
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adolescent polycystic ovary syndrome.
    Connor EL
    Adolesc Med State Art Rev; 2012 Apr; 23(1):164-77, xii. PubMed ID: 22764561
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Use of insulin-sensitizing agents in the treatment of polycystic ovary syndrome.
    Practice Committee of American Society for Reproductive Medicine
    Fertil Steril; 2008 Nov; 90(5 Suppl):S69-73. PubMed ID: 19007650
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Metformin for the treatment of the polycystic ovary syndrome.
    Barbieri RL; Gargiulo AR
    Minerva Ginecol; 2004 Feb; 56(1):63-79. PubMed ID: 14973411
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Polycystic ovary (Stein-Leventhal) syndrome: etiology, complications, and treatment.
    Hoyt KL; Schmidt MC
    Clin Lab Sci; 2004; 17(3):155-63. PubMed ID: 15314890
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [When and how should polycystic ovary syndrome be treated?].
    Martikainen H
    Duodecim; 2001; 117(13):1323-7; quiz 1327, 1341. PubMed ID: 12184121
    [No Abstract]   [Full Text] [Related]  

  • 28. Polycystic ovary syndrome.
    Homburg R
    Best Pract Res Clin Obstet Gynaecol; 2008 Apr; 22(2):261-74. PubMed ID: 17804299
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use of insulin sensitizing agents in the treatment of polycystic ovary syndrome.
    Practice Committee of the American Society for Reproductive Medicine
    Fertil Steril; 2006 Nov; 86(5 Suppl 1):S221-3. PubMed ID: 17055827
    [No Abstract]   [Full Text] [Related]  

  • 30. [Hirsutism].
    Frank-Raue K; Schulze E
    MMW Fortschr Med; 2003 Aug; 145(31-32):59-60. PubMed ID: 14524085
    [No Abstract]   [Full Text] [Related]  

  • 31. Insulin resistance and metformin in polycystic ovary syndrome.
    Ben-Haroush A; Yogev Y; Fisch B
    Eur J Obstet Gynecol Reprod Biol; 2004 Aug; 115(2):125-33. PubMed ID: 15262344
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Polycystic ovary syndrome and combined oral contraceptive use: a comparison of clinical practice in the United States to treatment guidelines.
    Bird ST; Hartzema AG; Etminan M; Brophy JM; Delaney JA
    Gynecol Endocrinol; 2013 Apr; 29(4):365-9. PubMed ID: 23311996
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Insulin sensitizing drugs increase the endogenous dopaminergic tone in obese insulin-resistant women with polycystic ovary syndrome.
    Ortega-González C; Cardoza L; Coutiño B; Hidalgo R; Arteaga-Troncoso G; Parra A
    J Endocrinol; 2005 Jan; 184(1):233-9. PubMed ID: 15642799
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metformin use in polycystic ovary syndrome: metabolic benefits and diabetes prevention.
    Goodarzi MO; Azziz R
    Am J Med; 2008 Aug; 121(8):e9; author reply e11. PubMed ID: 18691471
    [No Abstract]   [Full Text] [Related]  

  • 35. Use of metformin in polycystic ovary syndrome.
    Mathur R; Alexander CJ; Yano J; Trivax B; Azziz R
    Am J Obstet Gynecol; 2008 Dec; 199(6):596-609. PubMed ID: 19084097
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Polycystic ovarian syndrome: the next cardiovascular dilemma in women?
    Srikanthan P; Korenman S; Davis S
    Endocrinol Metab Clin North Am; 2006 Sep; 35(3):611-31, x. PubMed ID: 16959589
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment options of polycystic ovary syndrome in adolescence.
    Zapanti E; Kiapekou E; Loutradis D
    Pediatr Endocrinol Rev; 2006 Jan; 3 Suppl 1():208-13. PubMed ID: 16641862
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Metformin, an efficacious drug in the treatment of polycystic ovary syndrome].
    Hahn S; Quadbeck B; Elsenbruch S; Gärtner R; Finke R; Mann K; Janssen OE
    Dtsch Med Wochenschr; 2004 May; 129(19):1059-64. PubMed ID: 15136950
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Insulin resistance in polycystic ovary syndrome].
    Schröder AK; Tauchert S; Ortmann O; Diedrich K; Weiss JM
    Wien Klin Wochenschr; 2003 Dec; 115(23):812-21. PubMed ID: 14740344
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Polycystic ovary syndrome: a review for dermatologists: Part II. Treatment.
    Buzney E; Sheu J; Buzney C; Reynolds RV
    J Am Acad Dermatol; 2014 Nov; 71(5):859.e1-859.e15; quiz 873-4. PubMed ID: 25437978
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 49.